Sawai Group Holdings Co., Ltd. (TYO:4887)

Market Cap	209.02B
Revenue (ttm)	189.02B
Net Income (ttm)	11.97B
Shares Out	115.45M
EPS (ttm)	96.24
PE Ratio	103.63
Forward PE	11.91
Dividend	55.00 (3.05%)
Ex-Dividend Date	Sep 29, 2025

Volume	494,400
Average Volume	443,605
Open	1,825.50
Previous Close	1,810.50
Day's Range	1,819.00 - 1,847.00
52-Week Range	1,650.00 - 2,308.66
Beta	-0.03
RSI	53.66
Earnings Date	Aug 12, 2025

About Sawai Group Holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 3,310
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4887

Financial Performance

In 2024, Sawai Group Holdings's revenue was 189.02 billion, an increase of 6.88% compared to the previous year's 176.86 billion. Earnings were 11.97 billion, a decrease of -12.60%.